This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ngamying, M.
Right arrow Articles by Brennan, P. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ngamying, M.
Right arrow Articles by Brennan, P. J.

 Previous Article  |  Next Article 

Infection and Immunity, March 2003, p. 1596-1598, Vol. 71, No. 3
0019-9567/03/$08.00+0     DOI: 10.1128/IAI.71.3.1596-1598.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.

Effect of Vaccination with Refined Components of the Organism on Infection of Mice with Mycobacterium leprae

Maeya Ngamying,1 Pathom Sawanpanyalert,1 Raywadee Butraporn,1 Junjira Nikasri,1 Sang-Nae Cho,2 Louis Levy,1 and Patrick J. Brennan3*

National Institute of Health, Department of Medical Sciences, Ministry of Public Health, Nonthaburi 11000, Thailand,1 Department of Microbiology, Yonsei University, Seoul, Republic of Korea,2 Department of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, Colorado3

Received 6 September 2002/ Returned for modification 1 November 2002/ Accepted 25 November 2002

Only native products of Mycobacterium leprae, whether cell wall, cytosol, or membrane derived, can confer protective immunity against challenge in the mouse footpad. Previously, recombinant proteins were shown to be ineffective. The cell wall skeleton—the mycolyl-arabinogalactan-peptidoglycan complex—devoid of proteins is not protective.

* Corresponding author. Mailing address: Department of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, CO 80523-1677. Phone: (970) 491-6700. Fax: (970) 491-1815. E-mail: Patrick.Brennan{at}ColoState.edu.

Editor: W. A. Petri, Jr.

Infection and Immunity, March 2003, p. 1596-1598, Vol. 71, No. 3
0019-9567/03/$08.00+0     DOI: 10.1128/IAI.71.3.1596-1598.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Duthie, M. S., Goto, W., Ireton, G. C., Reece, S. T., Sampaio, L. H., Grassi, A. B., Sousa, A. L. M., Martelli, C. M. T., Stefani, M. M. A., Reed, S. G. (2008). Antigen-Specific T-Cell Responses of Leprosy Patients. CVI 15: 1659-1665 [Abstract] [Full Text]  
  • Scollard, D. M., Adams, L. B., Gillis, T. P., Krahenbuhl, J. L., Truman, R. W., Williams, D. L. (2006). The Continuing Challenges of Leprosy. Clin. Microbiol. Rev. 19: 338-381 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»